Skip to content

Author

R. Partl

We have 2 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

A European multicenter cohort study of patients with oligometastatic prostate cancer receiving stereotactic body radiotherapy for non-spinal bone metastases.

PURPOSE Stereotactic body radiotherapy (SBRT) is increasingly used for the treatment of bone metastases (BoM) of oligometastatic prostate cancer. This study aims to provide new information on SBRT for non-spinal BoM of oligometastatic prostate cancer in a large multicenter cohort. METHODS Retrospective data from 20 E...

F. Nagler, S. Schäfer, I. Seiler et al. · 0 citations
Open access Aug 2026

Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases

Clinical features remained the strongest predictors of risk across patients with brain metastases from different primary tumors, although, in melanoma patients, radiomic features provided better prediction of the survival outcome compared to clinical parameters alone.

J. Heugenhauser, Sabrina Herbst, T. Drucks et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.